Skip to main content

Featured

Stellantis May Abandon Brampton for Good: What It Means for Ontario Jobs

  Published August 18, 2026 With less than 24 hours left before Washington's 50% tariff deadline hits at 12:01 a.m. Wednesday, the headlines are all about cement, wine, and dairy. But the real fight holding up a deal is happening in the auto sector — and this week it collided with a story much closer to home: Stellantis is weighing whether to walk away from its Brampton, Ont. assembly plant for good. Put those two stories together and you get a clearer picture of what's actually at stake for Ontario workers, renters, and taxpayers than any tariff-deadline countdown can show on its own. The Trade Deal Is Stuck on Auto Rules, Not Wine or Cement Canadian and U.S. negotiators have been in Washington for a week trying to head off Trump's Section 338 tariffs — a rarely used trade law that, unlike earlier rounds, doesn't recognize USMCA certificates of origin for the goods it covers. Autos, alcohol, and dairy are all on the list, but autos are the sticking point. Canada is pu...

article

Provincial Directive Curbs AHS Authority Over Private Surgical Contract Negotiations

 


In a significant policy shift, Alberta Health Minister Adriana LaGrange has stripped Alberta Health Services (AHS) of its authority to negotiate contracts with private surgical facilities. According to a government directive obtained by media, the change came after internal concerns—raised by the agency’s then-chief executive—over rising contract costs.

Documents, including a letter from former AHS CEO Athana Mentzelopoulos’s lawyer, allege that senior government officials—even involving Premier Danielle Smith’s former chief of staff—intervened in AHS’s procurement process to favor private companies. This interference reportedly undermined AHS’s established negotiation powers and raised serious questions about transparency in the province’s health system. 

A separate report in a Morning Update from Unpublished Newswire reiterated the move, noting that the directive is part of broader reforms aimed at reducing costs by leveraging competitive pricing in surgical services.  Meanwhile, a CityNews investigation has added context to the controversy, citing denials by private surgical providers who label the allegations of sweetheart deals as “false and baseless.” 

Critics and opposition leaders are calling for further inquiry into the decision-making process behind these changes, arguing that the shift could signal a move toward greater privatization of public health services. In contrast, government representatives insist that the directive is intended solely to improve efficiency and ensure more competitive pricing for publicly funded operations.

Comments